Reports in category Initiating Coverage
Latest Research Reports On Stocks By Leading Brokerages: If you have any research reports that you would like to share with us, please send it to michael@rakesh-jhunjhunwala.in or to admin@rakesh-jhunjhunwala.in. (The pre-June 2016 reports are available here).
| Best 5 Specialty Ingredients Stocks To Buy Now: Research Report By Nirmal Bang | |
| Company: | Advanced Enzymes Technologies, Camlin Fine Sciences, Fine Organic, Galaxy Surfactants, Model Portfolio, Rossari Biotech |
| Brokerage: | Nirmal Bang |
| Date of report: | April 1, 2021 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 29% |
| Summary: | Indian companies are leveraging this opportunity whereby they deal with some global companies for sourcing ingredients and subsequently provide value-added solutions to clients based on their requirements |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Model Portfolio, Nirmal Bang, Speciality Chemicals |
| Gland Pharma Initiating Coverage Research Report By Axis Securities | |
| Company: | Gland Pharma Ltd |
| Brokerage: | Axis Securities |
| Date of report: | March 9, 2021 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 15% |
| Summary: | Well-positioned to Capitalise Fast-growing Generic Injectibles Market |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Axis Securities, Gland Pharma Ltd |
| Research Report On Burger Chains Stocks, Burger King & Westlife Development, By Prabhudas Lilladher | |
| Company: | Burger King India, Westlife Development |
| Brokerage: | Prabhudas Lilladher |
| Date of report: | February 28, 2021 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 52% |
| Summary: | A play on Brand pull and Technology |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Burger King India, Prabhudas Lilladher, Westlife Development |
| Buy Camlin Fine Sciences For 46% Upside Gain: Axis Securities | |
| Company: | Camlin Fine Sciences |
| Brokerage: | Axis Securities |
| Date of report: | February 19, 2021 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 46% |
| Summary: | Strategically Integrated Player |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Axis Securities, Camlin Fine Sciences |
| Strong Buy Reco Of Huhtamaki India Ltd By SMIFS | |
| Company: | Huhtamaki India Ltd |
| Brokerage: | Stewart & Mackertich |
| Date of report: | February 16, 2021 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 28.4% |
| Summary: | A proxy play on domestic FMCG and Pharma consumption |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Huhtamaki India Ltd, Stewart & Mackertich |
| DFM Foods Ltd: Research Report By SMIFS | |
| Company: | DFM Foods Ltd |
| Brokerage: | Stewart & Mackertich |
| Date of report: | February 9, 2021 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 32% |
| Summary: | High quality cash generating business with negative working capital |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | DFM Foods Ltd, Stewart & Mackertich |
| EIH Limited Research Report By Nirmal Bang | |
| Company: | EIH |
| Brokerage: | Nirmal Bang |
| Date of report: | January 16, 2021 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 19% |
| Summary: | Reduced pandemic impact, cyclical upswing, strong brand and locational advantage to drive growth |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | EIH, Nirmal Bang |
| Kolte Patil Developers Ltd (Mohnish Pabrai High-Conviction Portfolio Stock) Research Report By Edleweiss | |
| Company: | Kolte-Patil Developers |
| Brokerage: | Edelweiss |
| Date of report: | January 10, 2021 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 17% |
| Summary: | Scaling up for next leg of growth |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Edelweiss, Kolte-Patil Developers |
| Alembic Pharmaceuticals Research Report By IIFL | |
| Company: | Alembic Pharma |
| Brokerage: | IIFL |
| Date of report: | January 6, 2021 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 20% |
| Summary: | Strong all-round earnings |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Alembic Pharma, IIFL |
| Polycab India Research Report By Prabhudas Lilladher | |
| Company: | Polycab India |
| Brokerage: | Prabhudas Lilladher |
| Date of report: | January 5, 2021 |
| Type of Report: | |
| Recommendation: | Buy |
| Upside Potential: | 21% |
| Summary: | Evolving into a formidable FMEG player |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Polycab India, Prabhudas Lilladher |